118
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Synchronized release of bufadienolides in a stable Lutrol F127 based solid dispersion prepared with spray congealing

, , , , , & show all
Pages 1817-1825 | Received 08 Nov 2017, Accepted 12 Jul 2018, Published online: 31 Aug 2018

References

  • Mosquera-Giraldo LI, Taylor LS. Glass-liquid phase separation in highly supersaturated aqueous solutions of telaprevir. Mol Pharm. 2015;12:496–503.
  • Kendre PN, Chaudhari PD. Effect of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer on bio-adhesion and release rate property of eplerenone pellets. Drug Dev Ind Pharm. 2017;43:751–761.
  • Chakravarty P, Lubach JW, Hau J, et al. A rational approach towards development of amorphous solid dispersions: experimental and computational techniques. Int J Pharm. 2017;519:44–57.
  • Xie T, Taylor LS. Improved release of celecoxib from high drug loading amorphous solid dispersions formulated with polyacrylic acid and cellulose derivatives. Mol Pharm. 2016;13:873–884.
  • Sarode AL, Obara S, Tanno FK, et al. Stability assessment of hypromellose acetate succinate (HPMCAS) NF for application in hot melt extrusion (HME). Carbohydr Polym. 2014;101:146–153.
  • Trasi NS, Taylor LS. Dissolution performance of binary amorphous drug combinations–impact of a second drug on the maximum achievable supersaturation. Int J Pharm. 2015;496:282–290.
  • Riekes MK, Engelen A, Appeltans B, et al. New perspectives for fixed dose combinations of poorly water-soluble compounds: a case study with ezetimibe and lovastatin. Pharm Res. 2016;33:1259–1275.
  • Desale SS, Soni KS, Romanova S, et al. Targeted delivery of platinum-taxane combination therapy in ovarian cancer. J Control Release. 2015;220:651–659.
  • Wong PC, Heng PW, Chan LW. A study on the solid state characteristics of spray-congealed glyceryl dibehenate solid lipid microparticles containing ibuprofen. Drug Dev Ind Pharm. 2016;42:364–377.
  • Duarte I, Andrade R, Pinto JF, et al. Green production of cocrystals using a new solvent-free approach by spray congealing. Int J Pharm. 2016;506:68–78.
  • Cavallari C, Gonzalez-Rodriguez M, Tarterini F, et al. Image analysis of lutrol/gelucire/olanzapine microspheres prepared by ultrasound-assisted spray congealing. Eur J Pharma Biopharm. 2014;88:909–918.
  • Tian B, Zhang L, Pan Z, et al. A comparison of the effect of temperature and moisture on the solid dispersions: aging and crystallization. Int J Pharm. 2014;475:385–392.
  • Li F, Wang T, He HB, et al. The properties of bufadienolides-loaded nano-emulsion and submicro-emulsion during lyophilization. Int J Pharm. 2008;349:291–299.
  • Meng Q, Yau LF, Lu JG, et al. Chemical profiling and cytotoxicity assay of bufadienolides in toad venom and toad skin. J Ethnopharmacol. 2016;187:74–82.
  • Zhang DM, Liu JS, Tang MK, et al. Bufotalin from Venenum Bufonis inhibits growth of multidrug resistant HepG2 cells through G2/M cell cycle arrest and apoptosis. Eur J Pharm. 2012;692:19–28.
  • Fule RA, Meer TS, Sav AR, et al. Artemether-soluplus hot-melt extrudate solid dispersion systems for solubility and dissolution rate enhancement with amorphous state characteristics. J Pharm (Cairo). 2013;2013:151432
  • Jones DS, Tian Y, Li S, et al. The use of binary polymeric networks in stabilizing polyethylene oxide solid dispersions. J Pharm Sci. 2016;105:3064–3072.
  • Albertini B, Passerini N, Di Sabatino M, et al. Poloxamer 407 microspheres for orotransmucosal drug delivery. Part I: formulation, manufacturing and characterization. Int J Pharm. 2010;399:71–79.
  • Passerini N, Albertini B, Sabatino MD, et al. Development of microparticles for oral administration of the non-conventional radical scavenger IAC and testing in an inflammatory rat model. Int J Pharm. 2016;512:126–136.
  • Pozzoli M, Traini D, Young PM, et al. Development of a Soluplus budesonide freeze-dried powder for nasal drug delivery. Drug Dev Ind Pharm. 2017;43:1510–1518.
  • Parikh T, Gupta SS, Meena AK, et al. Application of film-casting technique to investigate drug-polymer miscibility in solid dispersion and hot-melt extrudate. J Pharm Sci. 2015;104:2142–2152.
  • Semjonov K, Kogermann K, Laidmae I, et al. The formation and physical stability of two-phase solid dispersion systems of indomethacin in supercooled molten mixtures with different matrix formers. Eur J Pharm Sci. 2017;97:237–246.
  • Zuo W, Qu W, Li N, et al. Fabrication of multicomponent amorphous bufadienolides nanosuspension with wet milling improves dissolution and stability. Artifi Cells Nanomed Biotechnol. 2018;46:1513–1522.
  • Mah PT, Peltonen L, Novakovic D, et al. The effect of surfactants on the dissolution behavior of amorphous formulations. Eur J Pharm Biopharm. 2016;103:13–22.
  • Singh A, Bharati A, Frederiks P, et al. Effect of compression on the molecular arrangement of itraconazole-soluplus solid dispersions: induction of liquid crystals or exacerbation of phase separation? Mol Pharm. 2016;13:1879–1893.
  • Jog R, Gokhale R, Burgess DJ. Solid state drug-polymer miscibility studies using the model drug ABT-102. Int J Pharm. 2016;509:285–295.
  • Xu M, Zhang C, Luo Y, et al. Application and functional characterization of POVACOAT, a hydrophilic co-polymer poly(vinyl alcohol/acrylic acid/methyl methacrylate) as a hot-melt extrusion carrier. Drug Dev Ind Pharm. 2014;40:126–135.
  • Ahuja N, Katare OP, Singh B. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers. Eur J Pharm Biopharm. 2007;65:26–38.
  • Curatolo W, Nightingale JA, Herbig SM. Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu. Pharm Res. 2009;26:1419–1431.
  • Fule R, Dhamecha D, Maniruzzaman M, et al. Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): evaluating amorphous state and in vivo performance. Int J Pharm. 2015;496:137–156.
  • Yun F, Kang A, Shan J, et al. Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement. Int J Pharm. 2014;465:436–443.
  • Medarevic DP, Kachrimanis K, Mitric M, et al. Dissolution rate enhancement and physicochemical characterization of carbamazepine-poloxamer solid dispersions. Pharm Dev Technol. 2016;21:268–276.
  • Lu C, Lu Y, Chen J, et al. Synchronized and sustained release of multiple components in silymarin from erodible glyceryl monostearate matrix system. Eur J Pharm Biopharm. 2007;66:210–219.
  • Wu Q, Kennedy MT, Nagapudi K, et al. Humidity induced phase transformation of poloxamer 188 and its effect on physical stability of amorphous solid dispersion of AMG 579, a PDE10A inhibitor. Int J Pharm. 2017;521:1–7.
  • Rumondor ACF, Taylor LS. Effect of polymer hygroscopicity on the phase behavior of amorphous solid dispersions in the presence of moisture. Mol Pharm. 2010;7:477–490.
  • Tran PH, Tran TT, Park JB, et al. Investigation of physicochemical factors affecting the stability of a pH-modulated solid dispersion and a tablet during storage. Int J Pharm. 2011;414:48–55.
  • Rumondor AC, Stanford LA, Taylor LS. Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions. Pharm Res. 2009;26:2599–2606.
  • Alshahrani SM, Morott JT, Alshetaili AS, et al. Influence of degassing on hot-melt extrusion process. Eur J Pharm Sci. 2015;80:43–52.
  • Weuts I, Kempen D, Verreck G, et al. Study of the physicochemical properties and stability of solid dispersions of loperamide and PEG6000 prepared by spray drying. Eur J PharmBiopharm. 2005;59:119–126.
  • Xie T, Taylor LS. Effect of Temperature and Moisture on the Physical Stability of Binary and Ternary Amorphous Solid Dispersions of Celecoxib. J Pharm Sci. 2017;106:100–110.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.